Vimian Group AB (publ) appoints Patrik Eriksson Chief Executive Officer, effective 1 January 2024. Patrik Eriksson joins Vimian from Envista, a global dental company listed on NYSE, where he currently serves on the Executive Team as President of Nobel Biocare. Patrik Eriksson (56) has vast international experience from 25 years as general manager in the global medtech and life science industries.

Since 2020, he is President of the dental company Nobel Biocare, part of Envista. Prior to that, he worked seven years at the global life sciences group Danaher (NYSE:DHR) as President of two of its medtech companies, KavoKerr and Ormco. He has led international organizations with more than 6,500 employees and revenues of USD 1.5 billion.

He is a Swedish citizen and holds a M.Sc. in Business and Administration from the Stockholm School of Economics. Patrik Eriksson succeeds Fredrik Ullman whose departure at year-end was announced on 29 June 2023.